In particular, somatic mutations of the BRAF gene encoding for a serine/threonine kinase that transduces regulatory signals from RAS through MEK to MAPK are detected in 40–60% of melanoma cases6, 7, 8, 9, 10. The gene discussed is MAP2K7; the disease is melanoma.